Lithium orotate
N/A
Report date: 2026/03/11 20:02:12
NME
Base Information
Drug NameLithium orotate
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJohns Hopkins University
China Registration ClassN/A
Develop Information
Active CompaniesCSPC Pharmaceutical Group LtdJohns Hopkins University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A